APA (7th ed.) Citation

Chen, S. T., & Hacke, W. (2017). Outcome of patients receiving thrombolytic therapy while on Rivaroxaban for nonvalvular atrial fibrillation (from Rivaroxaban once daily oral direct factor Xa inhibition compared with vitamin K antagonism for prevention of stroke and embolism trial in atrial fibrillation). The American journal of cardiology, 120(102), .

Chicago Style (17th ed.) Citation

Chen, Sean T., and Werner Hacke. "Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)." The American Journal of Cardiology 120, no. 102 (2017).

MLA (9th ed.) Citation

Chen, Sean T., and Werner Hacke. "Outcome of Patients Receiving Thrombolytic Therapy While on Rivaroxaban for Nonvalvular Atrial Fibrillation (from Rivaroxaban Once Daily Oral Direct Factor Xa Inhibition Compared with Vitamin K Antagonism for Prevention of Stroke and Embolism Trial in Atrial Fibrillation)." The American Journal of Cardiology, vol. 120, no. 102, 2017.